Global Antivenom Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

December 2018 | 131 pages | ID: G582EB7C908EN
GlobalInfoResearch

Abstracts

Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
Scope of the Report

This report focuses on the Antivenom in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Asia-Pacific Antivenom market is valued at 285.00 million USD in 2017 and is expected to reach 359.23 million USD by the end of 2023, growing at a CAGR of 43.93% between 2016 and 2022.
The price of Antivenom is slightly increased in nearly five years. For being accorded with the corresponding application area, the product price has a large differences.
Despite the presence of competition problems, due to the global recovery trend is clear, investors are still optimistic about this areas, the future will still have more new investment enter the field.
The worldwide market for Antivenom is expected to grow at a CAGR of roughly 2.5% over the next five years, will reach 960 million US$ in 2023, from 830 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• CSL Behring
• Merck & Co., Inc.
• BTG Plc
• Pfizer
• Haffkine Bio-Pharmaceutical Corporation
• Rare Disease Therapeutics
• Flynn Pharma
• Vins Bioproducts
• Bharat Serums and Vaccines
• Serum Biotech

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Polyvalent antivenom
• Monovalent antivenom

Market Segment by Applications, can be divided into

• Retail Pharmacies
• Hospitals
• Others

There are 15 Chapters to deeply display the global Antivenom market.

Chapter 1, to describe Antivenom Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Antivenom, with sales, revenue, and price of Antivenom, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Antivenom, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Antivenom market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Antivenom sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Antivenom Introduction
1.2 Market Analysis by Type
  1.2.1 Polyvalent antivenom
  1.2.2 Monovalent antivenom
1.3 Market Analysis by Applications
  1.3.1 Retail Pharmacies
  1.3.2 Hospitals
  1.3.3 Others
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 CSL Behring
  2.1.1 Business Overview
  2.1.2 Antivenom Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck & Co., Inc.
  2.2.1 Business Overview
  2.2.2 Antivenom Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 BTG Plc
  2.3.1 Business Overview
  2.3.2 Antivenom Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
  2.4.1 Business Overview
  2.4.2 Antivenom Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Haffkine Bio-Pharmaceutical Corporation
  2.5.1 Business Overview
  2.5.2 Antivenom Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Rare Disease Therapeutics
  2.6.1 Business Overview
  2.6.2 Antivenom Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Flynn Pharma
  2.7.1 Business Overview
  2.7.2 Antivenom Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Vins Bioproducts
  2.8.1 Business Overview
  2.8.2 Antivenom Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bharat Serums and Vaccines
  2.9.1 Business Overview
  2.9.2 Antivenom Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Serum Biotech
  2.10.1 Business Overview
  2.10.2 Antivenom Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL ANTIVENOM SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Antivenom Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antivenom Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Antivenom Manufacturer Market Share in 2017
  3.3.2 Top 6 Antivenom Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL ANTIVENOM MARKET ANALYSIS BY REGIONS

4.1 Global Antivenom Sales, Revenue and Market Share by Regions
  4.1.1 Global Antivenom Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Antivenom Revenue and Market Share by Regions (2013-2018)
4.2 North America Antivenom Sales and Growth Rate (2013-2018)
4.3 Europe Antivenom Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antivenom Sales and Growth Rate (2013-2018)
4.5 South America Antivenom Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antivenom Sales and Growth Rate (2013-2018)

5 NORTH AMERICA ANTIVENOM BY COUNTRIES

5.1 North America Antivenom Sales, Revenue and Market Share by Countries
  5.1.1 North America Antivenom Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Antivenom Revenue and Market Share by Countries (2013-2018)
5.2 United States Antivenom Sales and Growth Rate (2013-2018)
5.3 Canada Antivenom Sales and Growth Rate (2013-2018)
5.4 Mexico Antivenom Sales and Growth Rate (2013-2018)

6 EUROPE ANTIVENOM BY COUNTRIES

6.1 Europe Antivenom Sales, Revenue and Market Share by Countries
  6.1.1 Europe Antivenom Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Antivenom Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antivenom Sales and Growth Rate (2013-2018)
6.3 UK Antivenom Sales and Growth Rate (2013-2018)
6.4 France Antivenom Sales and Growth Rate (2013-2018)
6.5 Russia Antivenom Sales and Growth Rate (2013-2018)
6.6 Italy Antivenom Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC ANTIVENOM BY COUNTRIES

7.1 Asia-Pacific Antivenom Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Antivenom Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Antivenom Revenue and Market Share by Countries (2013-2018)
7.2 China Antivenom Sales and Growth Rate (2013-2018)
7.3 Japan Antivenom Sales and Growth Rate (2013-2018)
7.4 Korea Antivenom Sales and Growth Rate (2013-2018)
7.5 India Antivenom Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antivenom Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA ANTIVENOM BY COUNTRIES

8.1 South America Antivenom Sales, Revenue and Market Share by Countries
  8.1.1 South America Antivenom Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Antivenom Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antivenom Sales and Growth Rate (2013-2018)
8.3 Argentina Antivenom Sales and Growth Rate (2013-2018)
8.4 Colombia Antivenom Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA ANTIVENOM BY COUNTRIES

9.1 Middle East and Africa Antivenom Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Antivenom Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Antivenom Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antivenom Sales and Growth Rate (2013-2018)
9.3 UAE Antivenom Sales and Growth Rate (2013-2018)
9.4 Egypt Antivenom Sales and Growth Rate (2013-2018)
9.5 Nigeria Antivenom Sales and Growth Rate (2013-2018)
9.6 South Africa Antivenom Sales and Growth Rate (2013-2018)

10 GLOBAL ANTIVENOM MARKET SEGMENT BY TYPE

10.1 Global Antivenom Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Antivenom Sales and Market Share by Type (2013-2018)
  10.1.2 Global Antivenom Revenue and Market Share by Type (2013-2018)
10.2 Polyvalent antivenom Sales Growth and Price
  10.2.1 Global Polyvalent antivenom Sales Growth (2013-2018)
  10.2.2 Global Polyvalent antivenom Price (2013-2018)
10.3 Monovalent antivenom Sales Growth and Price
  10.3.1 Global Monovalent antivenom Sales Growth (2013-2018)
  10.3.2 Global Monovalent antivenom Price (2013-2018)

11 GLOBAL ANTIVENOM MARKET SEGMENT BY APPLICATION

11.1 Global Antivenom Sales Market Share by Application (2013-2018)
11.2 Retail Pharmacies Sales Growth (2013-2018)
11.3 Hospitals Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)

12 ANTIVENOM MARKET FORECAST (2018-2023)

12.1 Global Antivenom Sales, Revenue and Growth Rate (2018-2023)
12.2 Antivenom Market Forecast by Regions (2018-2023)
  12.2.1 North America Antivenom Market Forecast (2018-2023)
  12.2.2 Europe Antivenom Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Antivenom Market Forecast (2018-2023)
  12.2.4 South America Antivenom Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Antivenom Market Forecast (2018-2023)
12.3 Antivenom Market Forecast by Type (2018-2023)
  12.3.1 Global Antivenom Sales Forecast by Type (2018-2023)
  12.3.2 Global Antivenom Market Share Forecast by Type (2018-2023)
12.4 Antivenom Market Forecast by Application (2018-2023)
  12.4.1 Global Antivenom Sales Forecast by Application (2018-2023)
  12.4.2 Global Antivenom Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Antivenom Picture
Table Product Specifications of Antivenom
Figure Global Sales Market Share of Antivenom by Types in 2017
Table Antivenom Types for Major Manufacturers
Figure Polyvalent antivenom Picture
Figure Monovalent antivenom Picture
Figure Antivenom Sales Market Share by Applications in 2017
Figure Retail Pharmacies Picture
Figure Hospitals Picture
Figure Others Picture
Figure United States Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure France Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure UK Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure China Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure India Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Antivenom Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Antivenom Revenue (Value) and Growth Rate (2013-2023)
Table CSL Behring Basic Information, Manufacturing Base and Competitors
Table CSL Behring Antivenom Type and Applications
Table CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Antivenom Type and Applications
Table Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BTG Plc Basic Information, Manufacturing Base and Competitors
Table BTG Plc Antivenom Type and Applications
Table BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Antivenom Type and Applications
Table Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Haffkine Bio-Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Type and Applications
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rare Disease Therapeutics Basic Information, Manufacturing Base and Competitors
Table Rare Disease Therapeutics Antivenom Type and Applications
Table Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Flynn Pharma Basic Information, Manufacturing Base and Competitors
Table Flynn Pharma Antivenom Type and Applications
Table Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vins Bioproducts Basic Information, Manufacturing Base and Competitors
Table Vins Bioproducts Antivenom Type and Applications
Table Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bharat Serums and Vaccines Basic Information, Manufacturing Base and Competitors
Table Bharat Serums and Vaccines Antivenom Type and Applications
Table Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Serum Biotech Basic Information, Manufacturing Base and Competitors
Table Serum Biotech Antivenom Type and Applications
Table Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Antivenom Sales by Manufacturer (2016-2017)
Figure Global Antivenom Sales Market Share by Manufacturer in 2016
Figure Global Antivenom Sales Market Share by Manufacturer in 2017
Table Global Antivenom Revenue by Manufacturer (2016-2017)
Figure Global Antivenom Revenue Market Share by Manufacturer in 2016
Figure Global Antivenom Revenue Market Share by Manufacturer in 2017
Figure Top 3 Antivenom Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Antivenom Manufacturer (Revenue) Market Share in 2017
Figure Global Antivenom Sales and Growth Rate (2013-2018)
Figure Global Antivenom Revenue and Growth Rate (2013-2018)
Table Global Antivenom Sales by Regions (2013-2018)
Table Global Antivenom Sales Market Share by Regions (2013-2018)
Table Global Antivenom Revenue by Regions (2013-2018)
Figure Global Antivenom Revenue Market Share by Regions in 2013
Figure Global Antivenom Revenue Market Share by Regions in 2017
Figure North America Antivenom Sales and Growth Rate (2013-2018)
Figure Europe Antivenom Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antivenom Sales and Growth Rate (2013-2018)
Figure South America Antivenom Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antivenom Sales and Growth Rate (2013-2018)
Figure North America Antivenom Revenue and Growth Rate (2013-2018)
Table North America Antivenom Sales by Countries (2013-2018)
Table North America Antivenom Sales Market Share by Countries (2013-2018)
Figure North America Antivenom Sales Market Share by Countries in 2013
Figure North America Antivenom Sales Market Share by Countries in 2017
Table North America Antivenom Revenue by Countries (2013-2018)
Table North America Antivenom Revenue Market Share by Countries (2013-2018)
Figure North America Antivenom Revenue Market Share by Countries in 2013
Figure North America Antivenom Revenue Market Share by Countries in 2017
Figure United States Antivenom Sales and Growth Rate (2013-2018)
Figure Canada Antivenom Sales and Growth Rate (2013-2018)
Figure Mexico Antivenom Sales and Growth Rate (2013-2018)
Figure Europe Antivenom Revenue and Growth Rate (2013-2018)
Table Europe Antivenom Sales by Countries (2013-2018)
Table Europe Antivenom Sales Market Share by Countries (2013-2018)
Table Europe Antivenom Revenue by Countries (2013-2018)
Figure Europe Antivenom Revenue Market Share by Countries in 2016
Figure Europe Antivenom Revenue Market Share by Countries in 2017
Figure Germany Antivenom Sales and Growth Rate (2013-2018)
Figure UK Antivenom Sales and Growth Rate (2013-2018)
Figure France Antivenom Sales and Growth Rate (2013-2018)
Figure Russia Antivenom Sales and Growth Rate (2013-2018)
Figure Italy Antivenom Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antivenom Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Antivenom Sales by Countries (2013-2018)
Table Asia-Pacific Antivenom Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Antivenom Sales Market Share by Countries 2017
Table Asia-Pacific Antivenom Revenue by Countries (2013-2018)
Figure Asia-Pacific Antivenom Revenue Market Share by Countries 2017
Figure China Antivenom Sales and Growth Rate (2013-2018)
Figure Japan Antivenom Sales and Growth Rate (2013-2018)
Figure Korea Antivenom Sales and Growth Rate (2013-2018)
Figure India Antivenom Sales and Growth Rate (2013-2018)
Figure Southeast Asia Antivenom Sales and Growth Rate (2013-2018)
Figure South America Antivenom Revenue and Growth Rate (2013-2018)
Table South America Antivenom Sales by Countries (2013-2018)
Table South America Antivenom Sales Market Share by Countries (2013-2018)
Figure South America Antivenom Sales Market Share by Countries in 2017
Table South America Antivenom Revenue by Countries (2013-2018)
Table South America Antivenom Revenue Market Share by Countries (2013-2018)
Figure South America Antivenom Revenue Market Share by Countries in 2017
Figure Brazil Antivenom Sales and Growth Rate (2013-2018)
Figure Argentina Antivenom Sales and Growth Rate (2013-2018)
Figure Colombia Antivenom Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antivenom Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Antivenom Sales by Countries (2013-2018)
Table Middle East and Africa Antivenom Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Antivenom Sales Market Share by Countries in 2017
Table Middle East and Africa Antivenom Revenue by Countries (2013-2018)
Table Middle East and Africa Antivenom Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Antivenom Revenue Market Share by Countries in 2013
Figure Middle East and Africa Antivenom Revenue Market Share by Countries in 2017
Figure Saudi Arabia Antivenom Sales and Growth Rate (2013-2018)
Figure UAE Antivenom Sales and Growth Rate (2013-2018)
Figure Egypt Antivenom Sales and Growth Rate (2013-2018)
Figure Nigeria Antivenom Sales and Growth Rate (2013-2018)
Figure South Africa Antivenom Sales and Growth Rate (2013-2018)
Table Global Antivenom Sales by Type (2013-2018)
Table Global Antivenom Sales Share by Type (2013-2018)
Table Global Antivenom Revenue by Type (2013-2018)
Table Global Antivenom Revenue Share by Type (2013-2018)
Figure Global Polyvalent antivenom Sales Growth (2013-2018)
Figure Global Polyvalent antivenom Price (2013-2018)
Figure Global Monovalent antivenom Sales Growth (2013-2018)
Figure Global Monovalent antivenom Price (2013-2018)
Table Global Antivenom Sales by Application (2013-2018)
Table Global Antivenom Sales Share by Application (2013-2018)
Figure Global Hospitals Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Antivenom Sales, Revenue and Growth Rate (2018-2023)
Table Global Antivenom Sales Forecast by Regions (2018-2023)
Table Global Antivenom Market Share Forecast by Regions (2018-2023)
Figure North America Sales Antivenom Market Forecast (2018-2023)
Figure Europe Sales Antivenom Market Forecast (2018-2023)
Figure Asia-Pacific Sales Antivenom Market Forecast (2018-2023)
Figure South America Sales Antivenom Market Forecast (2018-2023)
Figure Middle East and Africa Sales Antivenom Market Forecast (2018-2023)
Table Global Antivenom Sales Forecast by Type (2018-2023)
Table Global Antivenom Market Share Forecast by Type (2018-2023)
Table Global Antivenom Sales Forecast by Application (2018-2023)
Table Global Antivenom Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List